Adaptive Biotechnologies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
ADPT Key Statistics
Stock Snapshot
As of today, Adaptive Biotechnologies(ADPT) shares are valued at $15.70. The company's market cap stands at 2.41B, with a P/E ratio of -39.55.
During the trading session on 2026-02-07, Adaptive Biotechnologies(ADPT) shares reached a daily high of $17.98 and a low of $15.07. At a current price of $15.70, the stock is +4.2% higher than the low and still -12.7% under the high.
Trading activity shows a volume of 4.14M, compared to an average daily volume of 2.12M.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.26.
Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.26.
ADPT News
TD Cowen raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $21 from $20 and keeps a Buy rating on the shares. The firm updated its model foll...
Advertisement Earnings and Guidance Put Adaptive Biotechnologies in Focus Adaptive Biotechnologies (ADPT) has come into focus after reporting fourth quarter a...
Reports Q4 revenue $71.68M, consensus $60.9M. The MRD business, which contributed 86% of revenue in the fourth quarter and 77% of revenue in the full year, grew...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.